Impact of Quality Indicators on Transplant Access: A Prospective Cohort Study in Australian Dialysis Patients
Nephrology · 2026
DOI: 10.1111/nep.70277 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nephrology, 2026. Verfasst von Rebecca Ling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia. Hauptthemen laut MEDLINE: Quality Indicators, Health Care, Kidney Transplantation, Waiting Lists, Renal Dialysis. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
In 2012, the Australian state of Victoria introduced a 6‐monthly reportable renal quality indicator (QI) for the proportion of patient's waitlisted or pre‐emptively transplanted by set time points after beginning kidney replacement therapy (KRT). This prospective cohort study aimed to determine if the QI influenced timeliness of transplant waitlisting for Victorians, compared to the rest of Australia as a control group.
Methods
Patients aged 18–70 commencing KRT between 2007 and 2020 were extracted from the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) and divided into three time eras. The primary outcome was the percentage of patients waitlisted or transplanted at 6, 12 and 24 months from starting KRT. Given the systematic disadvantage reported, specific analysis was performed to examine the QI's effect on Aboriginal and Torres Strait Islander people living in Victoria.
Results
Of 25 836 (14.7% Indigenous) patients starting dialysis, one third (8587, 5.7% Indigenous) were listed for transplant. Following implementation of the QI, the proportion of Victorian patients waitlisted within 6, 12 and 24‐months of starting KRT increased (adjusted OR [aOR] 1.85, 1.67 and 1.55 respectively; all p < 0.001). There was no significant change in Australian (non‐Victorian) rates at 6 and 12 months but a small increase was observed at 24 months.
Conclusion
Following introduction of the Victorian renal QI, the proportion of Victorian patients waitlisted at key timepoints improved more than patients in Australian states without QIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Nephrology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
- Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
- Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
- Kidney & Pancreas Transplant Unit, Monash Health, Clayton, Victoria, Australia.
- Central and Northern Adelaide Renal and Transplantation Services (CNARTS), Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Rebecca Ling, Christopher E Davies, Tia Mark, Stephen P McDonald, David J Goodman
Zitieren
APA
Ling, R., Davies, C. E., Mark, T., McDonald, S. P., & Goodman, D. J. (2026). Impact of Quality Indicators on Transplant Access: A Prospective Cohort Study in Australian Dialysis Patients. Nephrology. https://doi.org/10.1111/nep.70277
Vancouver
Ling R, Davies CE, Mark T, McDonald SP, Goodman DJ. Impact of Quality Indicators on Transplant Access: A Prospective Cohort Study in Australian Dialysis Patients. Nephrology. 2026. doi:10.1111/nep.70277
BibTeX
@article{Ling2026,
author = {Ling, Rebecca and Davies, Christopher E and Mark, Tia and McDonald, Stephen P and Goodman, David J},
title = {Impact of Quality Indicators on Transplant Access: A Prospective Cohort Study in Australian Dialysis Patients},
journal = {Nephrology},
year = {2026},
doi = {10.1111/nep.70277}
}
EUVIMED